Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q

View through CrossRef
Abstract Serum amyloid P component (SAP) was polymerized using the cleavable cross-linker 3,3’-dithio-bis-(sulfo-succinimidylpropionate) to study its interaction with the C system. Dimers and trimers, but no larger oligomers, were observed; the trimers retained native SAP immunoreactivity (except for one calcium-dependent epitope) without displaying neo-SAP epitopes. The SAP trimers bound strongly to C1q, at the level of the collagen-like region (CLR). SAP bound to synthetic C1q A chain peptides 14-26 and 76-92, and these peptides inhibited the binding of SAP trimers to the CLR. When incubated in dilute human serum, SAP trimers consumed total C and C4, but not alternative pathway, hemolytic activities. Consumption of C4 by SAP trimers was inhibited by C1q A chain peptide 14-26. Thus, SAP oligomers bind C1q and activate the classical C pathway via the collagen-like region of C1q, at sites located within residues 14-26 and/or 76-92 of the C1q A chain.
Title: Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q
Description:
Abstract Serum amyloid P component (SAP) was polymerized using the cleavable cross-linker 3,3’-dithio-bis-(sulfo-succinimidylpropionate) to study its interaction with the C system.
Dimers and trimers, but no larger oligomers, were observed; the trimers retained native SAP immunoreactivity (except for one calcium-dependent epitope) without displaying neo-SAP epitopes.
The SAP trimers bound strongly to C1q, at the level of the collagen-like region (CLR).
SAP bound to synthetic C1q A chain peptides 14-26 and 76-92, and these peptides inhibited the binding of SAP trimers to the CLR.
When incubated in dilute human serum, SAP trimers consumed total C and C4, but not alternative pathway, hemolytic activities.
Consumption of C4 by SAP trimers was inhibited by C1q A chain peptide 14-26.
Thus, SAP oligomers bind C1q and activate the classical C pathway via the collagen-like region of C1q, at sites located within residues 14-26 and/or 76-92 of the C1q A chain.

Related Results

The Role of the Classical and Alternate Complement Pathways in Host Defenses Against Cryptococcus Neoformans Infection
The Role of the Classical and Alternate Complement Pathways in Host Defenses Against Cryptococcus Neoformans Infection
Abstract The relationship between complement and the heat labile factors known to be necessary for phagocytosis of Cryptococcus neoformans by human leukocytes has be...
Molecular Mechanisms of Amyloid Oligomers Toxicity
Molecular Mechanisms of Amyloid Oligomers Toxicity
Amyloid oligomers have emerged as the most toxic species of amyloid-β (Aβ). This hypothesis might explain the lack of correlation between amyloid plaques and memo...
Reasons for undergoing amyloid imaging among cognitively unimpaired older adults
Reasons for undergoing amyloid imaging among cognitively unimpaired older adults
AbstractObjectivesPreclinical Alzheimer’s disease (AD) clinical trials screen cognitively unimpaired older adults for biomarker criteria and disclose their results. We examined whe...
The FK506 binding protein 13 kDa (FKBP13) interacts with the C-chain of complement C1q
The FK506 binding protein 13 kDa (FKBP13) interacts with the C-chain of complement C1q
Abstract Background The pharmacological action of specific immunosuppressants is mediated by immunophilins. While cyclosporin A bind...
Light-controlled molecular tweezers capture specific amyloid oligomers
Light-controlled molecular tweezers capture specific amyloid oligomers
Amyloid-β peptide (Aβ) oligomers, characteristic symptom of Alzheimer’s disease (AD), have been identified as the most neurotoxic species and significant contributors to neurodegen...

Back to Top